Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 4813-4822

  Crawford, Sue E ^a   Estes, Mary K ^a   Ciarlet, Max ^a   Barone, Christopher ^a   O'Neal, Christine M ^a   Cohen, Jean ^c   Conner, Margaret E ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; DIARRHEA; GASTROENTERITIS; IMMUNIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RABBIT; ROTAVIRUS; VIRUS INFECTION; VIRUS PARTICLE;

EID: 0033065426     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.4813-4822.1999     Document Type: Article

References (47)

1. Andrew, M. E., D. B. Boyle, B. E. H. Coupar, D. Reddy, A. R. Bellamy, and G. W. Both. 1992. Vaccinia-rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea. Vaccine 10:185-191.
2. Begue, R. E., P. Martin, and P. H. Dennehy. 1998. Serological responses by immunoblot following natural infection with rotavirus serotypes G1 and G4 in children. J. Med. Virol. 56:52-57.
3. Bishop, R. F., G. L. Barnes, E. Cipriani, and J. S. Lund. 1983. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N. Engl. J. Med. 309:72-76.
4. Borriello, S. P., and R. J. Carman. 1983. Association of iota-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits. J. Clin. Microbiol. 17:414-418.
5. Burns, J. W., H. B. Greenberg, R. D. Shaw, and M. K. Estes. 1988. Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J. Virol. 62:2164-2172.
6. Children's Vaccine Initiative. 1997. A global vaccine for a global disease - an end to rotavirus diarrhoea? CVI Forum 14:1-6.
7. Ciarlet, M., S. E. Crawford, C. Barone, A. Bertolotti-Ciarlet, M. K. Estes, and M. E. Conner. 1998. Subunit rotavirus vaccine administered parenterally to rabbits induces protective immunity. J. Virol. 72:9233-9246.
8. Ciartet, M., M. K. Estes, C. Barone, R. F. Ramig, and M. E. Conner. 1998. Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infection. J. Virol. 72:2341-2351.
9. Ciarlet, M., M. Hidalgo, M. Gorziglia, and F. Liprandi. 1994. Characterization of neutralization epitopes on the VP7 surface protein of serotype G11 porcine rotaviruses. J. Gen. Virol. 75:1867-1873.
10. Clark, H. F., P. A. Offit, R. W. Ellis, D. Krah, A. R. Shaw, J. J. Eiden, M. Pichichero, and J. J. Treanor. 1996. WC3 reassortant vaccines in children. Arch. Virol. Suppl. 12:187-198.
11. Conner, M. E., S. E. Crawford, C. Barone, and M. K. Estes. 1993. Rotavirus vaccine administered parenterally induces protective immunity. J. Virol. 67:6633-6641.
12. Conner, M. E., M. K. Estes, and D. Y. Graham. 1988. Rabbit model of rotavirus infection. J. Virol. 62:1625-1633.
13. Conner, M. E., M. A. Gilger, M. K. Estes, and D. Y. Graham. 1991. Serologic and mucosal immune response to rotavirus infection in the rabbit model. J. Virol. 65:2562-2571.
14. Conner, M. E., C. D. Zarley, B. Hu, S. Parsons, D. Drabinski, S. Greiner, R. Smith, B. Jiang, B. Corsaro, V. Barniak, H. P. Madore, S. E. Crawford, and M. K. Estes. 1996. Virus-like particles as a rotavirus subunit vaccine. J. Infect. Dis. 174:S88-S92.
15. Coulson, B. S., J. M. Tursi, W. J. McAdam, and R. F. Bishop. 1986. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Virology 154:302-312.
16. Crawford, S. E., M. Labbe, J. Cohen, M. H. Burroughs, Y. Zhou, and M. K. Estes. 1994. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J. Virol. 68:5945-5952.
17. Estes, M. K., S. E. Crawford, M. E. Peñaranda, B. L. Petrie, J. W. Burns, W. K. Chan, B. Ericson, G. E. Smith, and M. D. Summers. 1987. Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system. J. Virol. 61:1488-1494.
18. Estes, M. K., D. Y. Graham, C. P. Gerba, and E. M. Smith. 1979. Simian rotavirus SA11 replication in cell cultures. J. Virol. 31:810-815.
19. Estes, M. K., D. Y. Graham, R. F. Ramig, and B. L. Ericson. 1982. Heterogeneity in the structural glycoprotein (VP7) of simian rotavirus SA11. Virology 122:8-14.
20. Fernández, F. M., M. E. Conner, D. C. Hodgins, A. V. Parwani, P. R. Nielsen, S. E. Crawford, M. K. Estes, and L. J. Saif. 1998. Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines. Vaccine 16:507-516.
21. Flores, J., I. Pérez-Schael, M. Blanco, A. M. Rojas, E. Alfonzo, I. Crespo, W. Cunto, A. L. Pittman, and A. Z. Kapikian. 1993. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine. J. Clin. Microbiol. 31:2439-2445.
22. Gouvea, V., L. De Castro, M. do Carmo Timenetsky, H. Greenberg, and N. Santos. 1994. Rotavirus serotype GS associated with diarrhea in Brazilian children. J. Clin. Microbiol. 32:1408-1409.
23. Groene, W. S., and R. D. Shaw. 1992. Psoralen preparation of antigenically infact noninfectious rotavirus particles. J. Virol. Methods 38:93-102.
24. Hoshino, Y., R. W. Jones, and A. Z. Kapikian. 1998. Serotypic characterization of outer capsid spike protein VP4 of vervet monkey rotavirus SA11 strain. Arch. Virol. 143:1233-1244.
25. Institute of Medicine. 1986. New vaccine development. Establishing Priorities. Diseases of Importance in Developing Countries, vol. 2, p. 308-318. National Academy Press, Washington, D.C.
26. Jiang, B., C. Barone, V. Barniak, C. M. O'Neal, A. Ottaiano, H. P. Madore, M. K. Estes, and M. E. Conner. 1998. Heterotypic protection against rotavirus infection in mice vaccinated with virus-like particles. Vaccine 17:1005-1013.
27. Kapikian, A. Z., and R. M. Chanock. 1996. Rotaviruses, p. 1657-1708. In B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
28. Kensil, C. R., U. Patel, M. Lennick, and D. Marciani. 1991. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J. Immunol. 146:431-437.
29. Kensil, C. R., J.-Y. Wan, and S. Soltysik. 1995. Structural and immunological characterization of the vaccine adjuvant QS-21, p. 525-541. In M. F. Powell and M. J. Newman (ed.), Vaccine design: the subunit and adjuvant approach. Plenum Press, New York, N.Y.
30. Labbe, M., A. Charpilienne, S. E. Crawford, M. K. Estes, and J. Cohen. 1991. Expression of rotavirus VP2 produces empty corelike particles. J. Virol. 65:2946-2952.
31. LaCasse, R. A., K. E. Follis, M. Trahey, J. D. Scarborough, D. R. Littman, and J. H. Nunberg. 1999. Fusion-competent vaccines: broad neutralization of primary isolates of HIV. Science 283:357-362.
32. Mackow, E. R., P. T. Vo, R. Broome, D. Bass, and H. B. Greenberg. 1990. Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J. Virol. 64:1698-1703.
33. Madore, H. P., D. Zarley, B. Hu, S. Parsons, B. Jiang, B. Corsaro, S. E. Crawford, M. E. Conner, and M. K. Estes. 1999. Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine. Vaccine 17:2461-2471.
34. Matsui, S. M., P. A. Offit, P. T. Vo, E. R. Mackow, D. A. Benfield, R. D. Shaw, L. Padilla-Noriega, and H. B. Greenberg. 1989. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J. Clin. Microbiol. 27:780-782.
35. Menchaca, G., L. Padilla-Noriega, M. Méndez-Toss, J. F. Contreras, F. I. Puerto, H. Guiscafre, F. Mota, I. Herrera, R. Cedillo, O. Muñoz, R. Ward, Y. Hoshino, S. López, and C. F. Arias. 1998. Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children. Clin. Diagn. Lab. Immunol. 5:328-334.
36. Offit, P. A., and G. Blavat. 1986. Identification of the two rotavirus genes determining neutralization specificities. J. Virol. 57:376-378.
37. O'Neal, C. M., S. E. Crawford, M. K. Estes, and M. E. Conner. 1997. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 71:8707-8717.
38. Perez-Schael, I., M. Blanco, M. Vilar, D. Garcia, L. White, R. Gonzalez, A. Z. Kapikian, and J. Flores. 1990. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J. Clin. Microbiol. 28:553-558.
39. Perez-Schael, I., M. J. Guntinas, M. Perez, V. Pagone, A. M. Rojas, R. Gonzalez, W. Cunto, Y. Hoshino, and A. Z. Kapikian. 1997. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N. Engl. J. Med. 337:1181-1187.
40. Ramachandran, M., B. K. Das, A. Vij, R. Kumar, S. S. Bhambal, N. Kesari, H. Rawat, L. Bahl, S. Thakur, P. A. Woods, R. I. Glass, M. K. Bhan, and J. R. Gentsch. 1996. Unusual diversity of human rotavirus G and P genotypes in India. J. Clin. Microbiol. 34:436-439.
41. Ramachandran, M., J. R. Gentsch, U. D. Parashar, S. Jin, P. A. Woods, J. L. Holmes, C. D. Kirkwood, R. F. Bishop, H. B. Greenberg, S. Urasawa, G. Gerna, B. S. Coulson, K. Taniguchi, J. S. Bresee, and R. I. Glass. 1998. Detection and characterization of novel rotavirus strains in the United States. J. Clin. Microbiol. 36:3223-3229.
42. Santosham, M., L. H. Moulton, R. Reid, J. Croll, R. Weatherholt, R. Ward, J. Forro, M. Mack, G. Brenneman, and B. L. Davidson. 1997. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J. Pediatr. 131:632-638.
43. Smith, G. E., M. J. Fraser, and M. D. Summers. 1983. Molecular engineering of the Autographa californica nuclear polyhedrosis virus genome: deletion mutations within the polyhedrin gene. J. Virol. 46:584-593.
44. Snodgrass, D. R., T. A. Fitzgerald, I. Campbell, G. F. Browning, F. M. M. Scott, Y. Hoshino, and R. C. Davies. 1991. Homotypic and heterotypic serological responses to rotavirus neutralization epitopes in immunologically naive and experienced animals. J. Clin. Microbiol. 29:2668-2672.
45. Velazquez, F. R., D. O. Matson, J. J. Calva, M. L. Guerrero, A. L. Morrow, S. Carter-Campbell, R. I. Glass, M. K. Estes, L. K. Pickering, and M. Ruiz-Palactos. 1996. Rotavirus infection in infants as protection against subsequent infections. N. Engl. J. Med. 335:1022-1028.
46. Ward, R. L., D. R. Knowlton, H. B. Greenberg, G. M. Schiff, and D. I. Bernstein. 1990. Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J. Virol. 64:2687-2691.
47. Ward, R. L., M. M. McNeal, D. S. Sander, H. B. Greenberg, and D. I. Bernstein. 1993. Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children. J. Virol. 67:464-468.